An 82-year-old former president says his prostate cancer treatment worked as intended. The statement lands in a context where median survival for metastatic disease in men over 80 remains poor, and where presidential medical access differs sharply from standard Medicare care. The update raises questions about prognosis, replicability, and privilege.
💡 Frequently Asked Questions (FAQ)
- Q: Did Joe Biden’s prostate cancer treatment actually work?
- A: Biden stated his prostate cancer treatment worked as intended, though specific clinical details were not disclosed and outcomes vary widely for metastatic prostate cancer in men over 80.
- Q: What is the median survival for metastatic prostate cancer in men over 80?
- A: Median survival for metastatic prostate cancer in men over 80 remains poor, typically measured in months to a few years depending on overall health, disease stage, and access to care.
- Q: How does presidential medical care differ from standard Medicare care?
- A: Presidents receive immediate, specialized care from top specialists and resources that are largely inaccessible to most Medicare patients, creating a significant disparity in treatment options and outcomes.